Chemistry:5-Methylethylone
From HandWiki
| |
| Names | |
|---|---|
| Preferred IUPAC name
2-(Ethylamino)-1-(7-methyl-2H-1,3-benzodioxol-5-yl)ethan-1-one | |
| Other names
R-MMC; 3,4-Methylenedioxy-5-methyl-N-ethyl cathinone; 5-Methyl-βk-MDEA
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChemSpider | |
PubChem CID
|
|
| UNII | |
| |
| |
| Properties | |
| C13H17NO3 | |
| Molar mass | 235.283 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Tracking categories (test):
5-Methylethylone (5-methyl-βk-MDEA, 5ME) is an empathogen, stimulant and psychedelic drug of the amphetamine, phenethylamine, and cathinone chemical classes.[1] It is structurally related to ethylone, a novel designer drug. Relatively little data exists about the pharmacological properties, metabolism, and toxicity of 5-methylethylone, though it has been sold as a designer drug.[2][3]
Legal status
United States
5-Methylethylone is unscheduled in the United States, but it is not currently approved by the Food and Drug Administration for human consumption. The state of Vermont lists it as a regulated drug.[4]
See also
References
- ↑ "3,4-Methylenedioxy-5-methylethcathinone (hydrochloride)"]. Cayman Chemical. https://www.caymanchem.com/app/template/Product.vm/catalog/14078.
- ↑ "The effects and toxicity of cathinones from the users' perspectives: A qualitative study". Human Psychopharmacology 32 (3): e2610. May 2017. doi:10.1002/hup.2610. PMID 28631397.
- ↑ "The clinical challenges of synthetic cathinones". British Journal of Clinical Pharmacology 86 (3): 410–419. March 2020. doi:10.1111/bcp.14132. PMID 31674690.
- ↑ Regulated Drugs Rule, Vermont Health Regulations
 |  |
